Is NCT03235219 results overdue?

Yes — results are overdue. Primary completion was 2018-02-19; the FDAAA-801 reporting deadline (2019-02-19) passed 2725 days ago and no results are posted on ClinicalTrials.gov.

A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes Mellitus

NCT ID	NCT03235219 ↗
Sponsor	Janssen Research & Development, LLC (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2018-02-19 (ACTUAL)
Reporting deadline	2019-02-19 (completion + 365d)
Days overdue	2725
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `f47dd76bff7496d6…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03235219. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.